Skip to main content
. 2019 Jul 7;11(13):4547–4560. doi: 10.18632/aging.102068

Table 1. Baseline characteristics of the study participants, categorized according to the presence or absence of NAFLD.

Variable Men (n = 1,897) Women (n = 2,206)
Without NAFLD (n = 1,565) With NAFLD (n = 332) P Without NAFLD (n = 1,644) With NAFLD (n = 562) P
Age (years) 61.9 ± 8.7 59.5 ± 7.8 < 0.001 61.8 ± 9.1 62.0 ± 9.0 0.623
Weight (kg) 65.3 ± 8.3 78.0 ± 8.1 < 0.001 54.8 ± 6.4 65.6 ± 8.1 <0.001
Height (cm) 167.3 ± 6.1 168.0 ± 6.5 0.123 154.7 ± 5.9 154.0 ± 5.5 0.035
Body mass index (kg/m2) 23.3 ± 2.4 27.6 ± 2.4 <0.001 22.9 ± 2.3 27.6 ± 2.8 <0.001
Systolic BP (mmHg) 122.7 ± 15.7 125.3 ± 15.3 0.017 121.5 ± 17.7 127.0 ± 17.3 <0.001
Diastolic BP (mmHg) 76.4 ± 10.0 80.3 ± 10.6 <0.001 74.1 ± 9.7 76.5 ± 9.9 <0.001
Smoking habit (%) 0.215 0.753
Never 17.8 19.4 94.2 93.2
Past 50.9 55.3 2.8 3.4
Current 31.3 25.3 3.0 3.4
Resistance exercise (%) 0.068 0.068
None 66.4 73.0 84.0 88.2
Intermittent 14.2 9.6 9.2 5.9
Regular 19.4 17.3 6.8 5.9
Serum total cholesterol (mg/dL) 187.8 ± 34.6 191.5 ± 35.9 0.138 200.5 ± 35.8 195.9 ± 38.2 0.039
Serum triglycerides (mg/dL) 154.0 ± 121.7 196.8 ± 114.8 <0.001 125.2 ± 79.9 153.3 ± 75.5 <0.001
Fasting plasma glucose (mg/dL) 104.8 ± 24.9 116.2 ± 28.5 <0.001 99.4 ± 21.1 112.9 ± 30.1 <0.001
HbA1c (%) 5.85 ± 0.83 6.30 ± 1.10 <0.001 5.79 ± 0.70 6.25 ± 0.93 <0.001
Serum AST (IU/L) 23.8 ± 10.3 27.8 ± 13.0 <0.001 22.5 ± 8.2 25.3 ± 13.1 <0.001
Serum ALT (IU/L) 20.3 ± 9.8 38.9 ± 3.1 <0.001 17.2 ± 7.9 28.3 ± 17.4 <0.001
Hepatic steatosis index 30.4 ± 3.3 38.9 ± 3.1 <0.001 31.1 ± 2.8 39.0 ± 2.8 <0.001
Hand grip strength (kg force) 36.8 ± 7.3 38.1 ± 6.9 0.009 22.7 ± 4.9 22.8 ± 4.9 0.715

Values are presented as mean ± standard deviation, unless otherwise specified. Bold numbers indicate statistically significant values. NAFLD, non-alcoholic fatty liver disease; BP, blood pressure; HbA1c, glycated hemoglobin A1c; AST, aspartate aminotransferase; ALT, alanine aminotransferase.